A carregar...
ICER, ISPOR AND QALYs: Tales of Imaginary Worlds
Previous commentaries in the Formulary Evaluation section of INNOVATIONS in Pharmacy have pointed to the lack of credibility in modeled claims for cost-effectiveness and associated recommendations for pricing by the Institute for Clinical and Economic Review (ICER). The principal objection to ICER r...
Na minha lista:
| Publicado no: | Innov Pharm |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
University of Minnesota Libraries Publishing
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8051886/ https://ncbi.nlm.nih.gov/pubmed/34007578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.24926/iip.v10i4.2266 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|